Safehouse's Legal Hurdles Continue As DOJ Moves Against Overdose Prevention Sites

Zinger Key Points
  • Safehouse has been seeking court protection for what it hopes will be the first overdose prevention center in Philadelphia.
  • The DOJ challenged Safehouse's argument that its activities should be protected under the Controlled Substances Act.

The Department of Justice (DOJ) is asking a federal court to drop a case brought by the Philadelphia nonprofit organization Safehouse. The move follows a years-long legal hurdle around the legality of safe drug consumption sites.

What Happened: A motion to dismiss the case was filed on Friday, reported Marijuana Moment.

The DOJ challenged Safehouse's argument that its activities — operating spaces where people can legally inject heroin, fentanyl and other opiates under medical supervision — should be protected under the Controlled Substances Act based on religious freedom laws.

Safehouse has acknowledged that it is not a religious organization, undermining its exemption claim, the DOJ states.

See Also: Department Of Justice Asks Federal Court For Another Delay In A Safe Drug Consumption Site Lawsuit

"Safehouse believes that maintaining a supervised injection site for unlawful users of heroin, fentanyl, and other opioids would, in essence, do more good than harm," the department stated. "As Safehouse has emphasized throughout its pleading, this conclusion is not religious, but is a judgment based on Safehouse's opinions about social circumstances and medical policy."

DOJ requested several delays in the lawsuit so far to evaluate its position on the harm reduction centers.

Why It Matters: Safehouse initially filed a complaint in 2021 asking the court to protect what could have been the first overdose prevention center in Philadelphia against the "crackhouse statute," which condemns any location with the "purpose of manufacturing, distributing, or using any controlled substance."

That complaint was prompted by an earlier ruling by a three-judge panel of the 3rd U.S. Circuit Court of Appeals that Safehouse's activities would violate federal law, reversing a previous district court decision.

DOJ initially sued in 2019, under the Trump administration, to block Safehouse from opening a safe consumption site.

Judge Gerald A. McHugh, who has overseen the case from the start, initially rejected DOJ's arguments — a ruling that the 3rd U.S. Circuit Court of Appeals overturned in 2021.

Pennsylvania Coalition Denied Request To Intervene

A coalition of Pennsylvania community groups that sought to intervene in the lawsuit as party-plaintiffs were denied their request on Monday by the U.S. District Court for the Eastern District of Pennsylvania.

The coalition raised concerns in April around the DOJ's plans to back off of the lawsuit it filed under the Trump administration.

"The Community Groups seek immediate intervention to protect the interests the Government may imminently abandon," the group said at the time. "For decades, the Community Groups' members have suffered the consequences of their neighborhoods' infestation with crime and drugs."

Judge McHugh wrote the group's motion "misunderstands the Government's current position, and the Government's recent Motion to Dismiss seeks to enforce Section 856 by vigorously defending against Safehouse's counterclaims."

He also rejected an amicus brief submitted by the four Pennsylvania lawmakers earlier this year against any agreement in the lawsuit.

The Benzinga Cannabis Capital Conference, the place where deals get done, is returning to Chicago this Sept 27-28 for its 17th edition. Get your tickets today before prices increase and secure a spot at the epicenter of cannabis investment and branding.

Photo: Courtesy of Diana Polekhina on Unsplash

Market News and Data brought to you by Benzinga APIs
Posted In: CannabisGovernmentNewsRegulationsPoliticsLegalTop StoriesMarketsGeneralDOJGerald A. McHughSafe consumption SitesSafehouse
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...